Thomas Curley, MD
Internal Medicine · Pittsburgh, PANPI 1942705835
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 6 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 6 manufacturers reported payments, led by ADC Therapeutics America, Inc. at 31.3% of the total.
Across 6 payments — averaging $66.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- ADC Therapeutics America, Inc.$125
- Gilead$118
- E.r. Squibb & Sons, L.L.C.$80
- Johnson & Johnson$36
- Incyte Corporation$26
- Genmab U.S., Inc.$15
Across 39 payments — averaging $5462.51 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Iovance Biotherapeutics, Inc.$213K
What the payments were for
- Food & beverage$399100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| ADC Therapeutics America, Inc. | 1 | $125 |
| Gilead | 1 | $118 |
| E.r. Squibb & Sons, L.L.C. | 1 | $80 |
| Johnson & Johnson | 1 | $36 |
| Incyte Corporation | 1 | $26 |
| Genmab U.S., Inc. | 1 | $15 |
How this compares
$399 in reported general payments places this provider in the 65th percentile of 5,705 internal medicine providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other internal medicine in Pittsburgh
- Donald MiddletonPittsburgh$258K
- Enrico NovelliPittsburgh$176K
- Sandra SobelPittsburgh$176K
- Abdullah AzharPittsburgh$120K
- Bassel SayeghPittsburgh$77K
- Liza VillaruzPittsburgh$53K
- David MillerPittsburgh$50K
- Jonathan EpsteinPhiladelphia$13.1M
- Pitamber DevgonPhiladelphia$7.5M
- Daniel RaderPhiladelphia$1.7M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.